M
Maros Ferencik
Researcher at Oregon Health & Science University
Publications - 258
Citations - 12052
Maros Ferencik is an academic researcher from Oregon Health & Science University. The author has contributed to research in topics: Coronary artery disease & Acute coronary syndrome. The author has an hindex of 52, co-authored 229 publications receiving 10397 citations. Previous affiliations of Maros Ferencik include Cardiovascular Institute of the South & Harvard University.
Papers
More filters
Journal ArticleDOI
Coronary CT Angiography for the Detection of Obstructive Coronary Artery Disease
TL;DR: Coronary CT angiography is an appropriate diagnostic test for a selected patient population with a low to intermediate probability of coronary artery disease.
Journal ArticleDOI
Risk factors for cardiovascular disease among individuals with hepatic steatosis
Júlia Karády,Maros Ferencik,Thomas Mayrhofer,Nandini M. Meyersohn,Daniel O. Bittner,Pedro V. Staziaki,Bálint Szilveszter,Travis R. Hallett,Michael T. Lu,Stefan Puchner,Tracey G. Simon,Borek Foldyna,Geoffrey S. Ginsburg,Robert W. McGarrah,Deepak Voora,Svati H. Shah,Pamela S. Douglas,Udo Hoffmann,Kathleen E. Corey +18 more
TL;DR: In individuals with HS, male sex, NT-pro-BNP, and ASCVD risk score are associated with obstructive CAD, and these factors, with further validation, may help risk-stratify adults with HS for incident CAD and MACE.
Journal ArticleDOI
The Potential Role of Combined Highly Sensitive Troponin and Coronary Computed Tomography Angiography in the Evaluation of Patients with Suspected Acute Coronary Syndrome in the Emergency Department
TL;DR: This review will summarize the experience and evidence for the use of highly sensitive troponin (hsTn) in the rapid and efficient evaluation of patients with suspected acute coronary syndrome and discuss the opportunities for the combined use of hsTn and coronary CTA in this population.
Journal ArticleDOI
Small whole heart volume predicts cardiovascular events in patients with stable chest pain: insights from the PROMISE trial
Borek Foldyna,Roman Zeleznik,Parastou Eslami,Thomas Mayrhofer,Jan-Erik Scholtz,Jan-Erik Scholtz,Maros Ferencik,Maros Ferencik,Daniel O. Bittner,Daniel O. Bittner,Nandini M. Meyersohn,Stefan Puchner,Stefan Puchner,Hamed Emami,Patricia A. Pellikka,Hugo J.W.L. Aerts,Hugo J.W.L. Aerts,Pamela S. Douglas,Michael T. Lu,Udo Hoffmann +19 more
TL;DR: In this paper, the authors evaluated the prognostic value of 3D whole heart volume (WHV) derived from non-contrast cardiac computed tomography (CT) among participants randomized to the CT arm of the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE).
Journal ArticleDOI
The inhibitory effect of homologous immunoglobulin G on the degradation of antigen (human serum albumin) by rabbit cathepsin D
J. Štefanovič,Maros Ferencik +1 more
TL;DR: The studies on the kinetics of inhibition showed that the authors were probably dealing with a special case of inhibition of the mixed type which is known as coupling or anticompetitive inhibition.